Myeloma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with multiple myeloma and have had blood (serum) samples tested using specific protein analysis methods
- Healthy individuals with no obvious illness and a normal health check report, who have not had major long-term conditions such as high blood pressure, diabetes, or chronic kidney disease in recent years, and who are a similar age and sex to the multiple myeloma patients in the study
Who may not be able to join:
- People whose sample records are incomplete or whose samples cannot be traced back to their source
- People whose blood sample does not contain enough material to carry out the required testing
- People whose blood sample was not collected or stored in the way required by the study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Hongwei Zhou, Professor, Zhujiang Hospital
Phone: 13928801657
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
M-protein
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.